| |
Gan & Lee Pharmaceutical Co., Ltd.
|
| Basalin(Insulin Glargine) |
|
|
|
Product Features |
| Special features: |
the only true basal insulin analog, offers patients once-daily administration and peakless action, reduces the risk of hyperglycemia, and improves metabolic control |
|
|
|
| Quality certification: |
GMP, Amercia Patent, Russia Patent |
|
| Capability: |
8 million cartriges/year 4 million vials/year |
|
|
|
|
|
|
|
| Description: |
Our product, recombinant insulin glargine, named Basalin, is the only true basal insulin analog, offers patients once-daily administration and peakless action, reduces the risk of hyperglycemia, and improves metabolic control.
About Why you choose us
1.Only Ganlee Ltd. and Sanofi-aventis are capable of producing the Recombinant Insulin Glargine in the whole world.
2.Our production standard is higher than EP and USP.
3.The purity of products is up to 99.66%, higher than average value, 99.34%.
4.We have achieved PCT patent from America and Russia and many other countries. It is welcomed in the world wide.
5.Competitive price compare to the congeneric insulin, can enhance your competition.
6.Product advantages:
-Constant and prolonging action. Basalin has been proven to lower basal glucose levels for a full 24 hours.
-Efficient and easy to reach the target. Once-daily administration and peakless action.
-Safe and reliable to lower glucose level. Reduces the risk of hyperglycemia dramatically. |
|
 |
|
|